Drones Could Deliver Defibrillators or AEDs to sudden Cardiac Arrest Victims Faster Than Ambulances. Getty Images
September 01, 2021
Drones Could Deliver Defibrillators to Cardiac Arrest Victims Faster Than Ambulances
September 1, 2021 — The world’s first feasibility study has found that drones can be used to deliver life-saving…
Read More
One-month Clopidogrel Monotherapy After PCI Not Supported in STOPDAPT-2 ACS Trial 
September 01, 2021
One-month Clopidogrel Monotherapy After PCI Not Supported in STOPDAPT-2 ACS Trial 
September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT)…
Read More
The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.
September 01, 2021
Edoxaban May Be Effective Treatment for Atrial Fibrillation After TAVR 
September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart…
Read More
The Stereotaxis Genesis EP robotic navigation system.
September 01, 2021
Stereotaxis and Microport EP Partner to Commercialize Electrophysiology Robotics in China
September 1, 2021 — Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance…
Read More
A team at the University of South Australia designed a computer vision system that can automatically detect a baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as a traditional ECG machine.
September 01, 2021
Noncontact ECG Monitoring a Step Closer for Neonatal Wards
September 1, 2021 — University of South Australia researchers have designed a computer vision system that can…
Read More
Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to Watchman
August 31, 2021
Abbott Amplatzer Amulet LAA Occluder Offers Superior Closure Compared to Watchman
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA)…
Read More
#breakingnews The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. It is the first vaccine to be fully approved by the FDA, and experts say it is expected to open the door for further vaccine mandates.
August 23, 2021
Pfizer-BioNTech COVID-19 Vaccine Gets Full Approval from FDA
August 23, 2021 — The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech COVID-…
Read More
An example at HIMSS of deeper third-party software integration in enterprise imaging platforms was Siemens Healthcare showing a new, deep integration with echocardiography strain imaging analysis provider Epsilon Imaging. The integration eliminates the need for a separate login and the Epsilon software is now just a tool option available in the syngo system and it carries over data and images directly into the echo report.
By Dave Fornell, Editor
August 20, 2021
Advances in PACS and Cardiology Information Systems at HIMSS 2021
Taking advantage of new technology advances, several radiology PACS, enterprise imaging and cardiovascular information…
Read More
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed’s new Impella ECP expandable percutaneous heart pump. The designation means the FDA will prioritize Impella ECP’s regulatory review processes including design iterations, clinical study protocols and pre-market approval (PMA) application.
August 20, 2021
FDA Grants Breakthrough Device Designation to Impella ECP
August 20, 2021 – The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed’s…
Read More
The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compromised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images #AHA #coronavirus #COVID19
By Dave Fornell, Editor
August 18, 2021
American Heart Association Supports COVID Vaccine Boosters Suggested by the CDC
August 18, 2021 — The U.S. Centers for Disease Control and Prevention (CDC) recommended Friday a third dose of the…
Read More
A comparison of color-flow Doppler cardiac ultrasound showing blood flow, and blood speckle tracking revealing a more detailed and complex understanding of the low. It shows the formation of a vortex that may play a role in future assessments for the efficiency of flow in the heart and vessels. #ASE21 #ASE2021 #Vectorflowimaging
By Dave Fornell, Editor
August 17, 2021
Development of Echo Blood Flow Dynamics Imaging
In the past several years, a few cardiac ultrasound vendors have developed new ways to image the intricate flow of…
Read More
The Abbott Amplatzer Amulet left atrial appendage (LAA) transcatheter occlusion device. It received FDA clearance in August 2021. #LAA
August 16, 2021
FDA Clears Abbott Amplatzer Amulet LAA Occluder to Reduce Stroke in People With Atrial Fibrillation
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage…
Read More
Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE).
August 09, 2021
Study Compares Interventional Pulmonary Embolism Therapy in Combination With Anticoagulation to Anticoagulation Alone
August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative…
Read More
BioMonitor IIIm is a miniature electrocardiogram (ECG) device which records, stores and transmits clinical data that is integral in the diagnosis and long-term monitoring of cardiac patients, with maximum precision and for an extended period of time.
August 09, 2021
Biotronik Implantable Cardiac Monitor Receives Prestigious Industry Award
August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac…
Read More
Ventricular Tachycardia Recurrence, Hospitalization and Death Reduced With Catheter Ablation as First Line Therapy. Results from an international clinical trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalization, and sudden cardiac death (SCD) death when catheter ablation is used as an early first-line treatment for patients with structural heart disease. Led by study coordinating center, the University of Chicago, The PAUSE-SCD trial. #HRS21
August 09, 2021
Ventricular Tachycardia Recurrence, Hospitalization and Death Reduced With Catheter Ablation as First Line Therapy
August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular…
Read More
The Adagio Medical iCLAS cryoablation system is commercial in Europe and is also part of an ongoing FDA IDE trial in the U.S. #HRS21
August 09, 2021
Pulsed Field Cryoablation Eliminated AF in 85% After Single Ablation Procedure
August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and…
Read More
Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21
August 09, 2021
Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology
July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them…
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death
August 09, 2021
Boston Scientific Recalls INGENIO Family of Pacemakers
August 9, 2021 — Boston Scientific is recalling INGENIO family of pacemakers and CRT-Ps due to the risk of incorrect…
Read More
An example from the study of the Biosense Webster NuVision 3D/4D ICE imaging capability showing the left atrial appendage (LAA) visualization on 3D ICE. The system allows the user to place a false lighting source to be placed in different positions to change the lighting and shadows to better visualize the anatomy.
By Dave Fornell, Editor
August 05, 2021
First-in-Human Experience With Novel 4D ICE Catheter For Catheter Ablation and LAA Closure Procedures
August 5, 2021 —  A prospective, non-randomized, multicenter, first-in-human clinical study found good diagnostic and…
Read More
Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.
August 05, 2021
FDA Clears Abbott OCT Imaging Enhanced With Artificial Intelligence
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now